European Case Law Identifier: | ECLI:EP:BA:2015:T173410.20150929 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 29 September 2015 | ||||||||
Case number: | T 1734/10 | ||||||||
Application number: | 99940722.4 | ||||||||
IPC class: | C07K 14/435 A61K 38/17 A61P 35/00 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | D | ||||||||
Download and more information: |
|
||||||||
Title of application: | Peptides that elicit T cellular immunity | ||||||||
Applicant name: | GemVax AS | ||||||||
Opponent name: | - | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Remittal to the department of first instance - (no) Auxiliary request 1 to 11 - sufficiency of disclosure Auxiliary request 1 to 11 - (no) Auxiliary request 12 - requirements of the EPC met Auxiliary request 12 - (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t101734eu1.html
Date retrieved: 17 May 2021